Moran Kyle, CFO of Wave Life Sciences Ltd. ($WVE), sold about $4.15 million in company shares across seven open market transactions over the past year. His most recent sale occurred on February 9, 2026. These sales rank 2,202nd among 11,678 individual insiders in our database, where the average is $8.6 million across roughly six transactions. Kyle made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2026 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | A | Ordinary Shares | 45625 | $0.00 | 137,973.0000 | 167,739,208 | 49.41% | 0.03% |
| Feb. 5, 2026 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | A | Share Option (right to buy) | 273750 | $0.00 | 273,750.0000 | 167,739,208 | 9999.99% | 0.16% |
| Feb. 9, 2026 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | S | Ordinary Shares | 3588 | $13.45 | 134,385.0000 | 167,739,208 | 2.60% | 0.00% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | S | Ordinary Shares | 50000 | $13.20 | 89,218.0000 | 167,739,208 | 35.91% | 0.03% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | S | Ordinary Shares | 50000 | $18.00 | 89,218.0000 | 167,739,208 | 35.91% | 0.03% |
| Dec. 9, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | M | Ordinary Shares | 36000 | $8.17 | 125,218.0000 | 167,739,208 | 40.35% | 0.02% |
| Dec. 9, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | S | Ordinary Shares | 36 | $20.25 | 89,218.0000 | 167,739,208 | 0.04% | 0.00% |
| Dec. 9, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | M | Ordinary Shares | 50000 | $10.48 | 139,218.0000 | 167,739,208 | 56.04% | 0.03% |
| Dec. 9, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | S | Ordinary Shares | 50000 | $20.03 | 90,365.0000 | 167,739,208 | 35.62% | 0.03% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | A | Share Option (right to buy) | 60000 | $0.00 | 0.0000 | 167,739,208 | 100.00% | 0.04% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | A | Share Option (right to buy) | 100000 | $0.00 | 75,000.0000 | 167,739,208 | 57.14% | 0.06% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | A | Share Option (right to buy) | 50000 | $0.00 | 222,700.0000 | 167,739,208 | 18.34% | 0.03% |
| Dec. 9, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | A | Share Option (right to buy) | 36000 | $0.00 | 0.0000 | 167,739,208 | 100.00% | 0.02% |
| Dec. 9, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | A | Share Option (right to buy) | 50000 | $0.00 | 0.0000 | 167,739,208 | 100.00% | 0.03% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | M | Ordinary Shares | 60000 | $2.83 | 149,218.0000 | 167,739,208 | 67.25% | 0.04% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | S | Ordinary Shares | 60000 | $13.20 | 89,218.0000 | 167,739,208 | 40.21% | 0.04% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | M | Ordinary Shares | 100000 | $3.14 | 189,218.0000 | 167,739,208 | 112.09% | 0.06% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | S | Ordinary Shares | 50000 | $15.00 | 139,218.0000 | 167,739,208 | 26.42% | 0.03% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | M | Ordinary Shares | 50000 | $4.75 | 139,218.0000 | 167,739,208 | 56.04% | 0.03% |
| Feb. 4, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | A | Ordinary Shares | 42000 | $0.00 | 89,218.0000 | 138,277,468 | 88.95% | 0.03% |
| Feb. 4, 2025 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | A | Share Option (right to buy) | 252000 | $0.00 | 252,000.0000 | 138,277,468 | 9999.99% | 0.18% |
| Oct. 11, 2024 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | M | Share Option (right to buy) | 25000 | $0.00 | 0.0000 | 132,563,467 | 100.00% | 0.02% |
| Oct. 11, 2024 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | M | Ordinary Shares | 25000 | $2.48 | 44,777.0000 | 132,563,467 | 126.41% | 0.02% |
| Sept. 25, 2024 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | S | Ordinary Shares | 17146 | $9.00 | 19,777.0000 | 106,097,268 | 46.44% | 0.02% |
| April 3, 2024 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | S | Ordinary Shares | 15630 | $6.17 | 33,921.0000 | 106,097,268 | 31.54% | 0.01% |
| Feb. 5, 2024 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | A | Share Option (right to buy) | 371500 | $0.00 | 371,500.0000 | 106,097,268 | 9999.99% | 0.35% |
| Aug. 23, 2023 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | S | Ordinary Shares | 37062 | $4.75 | 46,120.0000 | 78,855,810 | 44.56% | 0.05% |
| Feb. 17, 2023 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | A | Share Option (right to buy) | 272700 | $0.00 | 272,700.0000 | 78,855,810 | 9999.99% | 0.35% |
| Feb. 16, 2023 | Wave Life Sciences Ltd. | $WVE | Moran Kyle | Chief Financial Officer | S | Ordinary Shares | 9729 | $4.04 | 79,751.0000 | 78,855,810 | 10.87% | 0.01% |